Calcium phosphate granules for use as a 5-Fluorouracil delivery system

Ceramics International

Volumn 35, Issue 4, 2009, Pages 1587-1594

  Santos, C ^a   Martins, M A ^a   Franke, R P ^b   Almeida, M M ^a   Costa, M E V ^a  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

5 Fluorouracil; D. Apatite; E. Biomedical applications; Spray drying

Indexed keywords

BIOMATERIALS; CALCIUM; CALCIUM PHOSPHATE; CONTROLLED DRUG DELIVERY; CRYSTALLINE MATERIALS; DEWATERING; GRANULATION; HAZARDOUS MATERIALS; HYDROXYAPATITE; PHOSPHATE MINERALS; SPECIFIC SURFACE AREA; SPRAY DRYING; SURFACES; SUSPENSIONS (FLUIDS);

5-FLUOROURACIL; 5-FLUOROURACIL DELIVERIES; ADVANCED MATERIALS; BIPHASIC; CITRATE SOLUTIONS; CONTROLLED RELEASE SYSTEMS; CRYSTAL PHASE COMPOSITIONS; D. APATITE; DRUG DELIVERY SYSTEMS; DRUG MODELS; E. BIOMEDICAL APPLICATIONS; HIGH POROSITIES; HIGH SPECIFIC SURFACE AREAS; PHOSPHATE-BUFFERED SOLUTIONS; POROUS HYDROXYAPATITES; RELEASE PROFILES; ROOM TEMPERATURES; SPECIFIC SURFACES; SURFACE AREAS; SURFACE CHEMICAL COMPOSITIONS; TRI CALCIUM PHOSPHATES;

APATITE;

EID: 61449111876     PISSN: 02728842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceramint.2008.08.015     Document Type: Article

References (43)

1. Martins M.A., Santos C., Costa M.E.V., and Almeida M.M. Preparation of porous hydroxyapatite particles to be used as drug delivery systems. Advanced Materials Forum II 455 (2004) 353-357
2. Franke R.-P., Santos C., Scharnweber T., Almeida M.M., and Costa M.E.V. Influence of nanostructured calcium-phosphate particles on rat osteosarcoma cells. Basic and Clinical Pharmacology and Toxicology 101 5 (2007) 360-1360
3. Cüneyt Tas A., Korkusuz F., Timuçin M., and Akkas N. An investigation of the chemical synthesis and high-temperature sintering behaviour of calcium hydroxyapatite (HA) and tricalcium phosphate (TCP) bioceramics. Journal of Materials Science: Materials in Medicine 8 (1997) 91-96
4. Bow J.-S., Liou S.-c., and Chen S.-Y. Structural characterization of room-temperature synthesized nano-sized β-tricalcium phosphate. Biomaterials 25 (2004) 3155-3161
5. Oktar F.N. Microstructure and mechanical properties of sintered enamel hydroxyapatite. Ceramics International 33 7 (2007) 1309-1314
6. Markovic M., Fowler B.O., and Tung M.S. Preparation and comprehensive characterization of a calcium hydroxyapatite reference material. Journal of Research of the National Institute of Standards and Technology 109 6 (2004) 553-568
7. Wang Y., Zhang S., Wei K., Zhao N., Chen J., and Wang X. Hydrothermal synthesis of hydroxyapatite nanopowders using cationic surfactant as templates. Materials Letters 60 (2006) 1484-1487
8. Livingston T.L., Gordon S., Archambault M., Kadiyala S., Mcintosh K., Smith A., and Peter S.J. Mesenchymal stem cells combined with biphasic calcium phosphate ceramics promote bone regeneration. Journal of Materials Science: Materials in Medicine 14 (2003) 211-218
9. Elliott J.C. Structure and Chemistry of the Apatites and Other Calcium Orthophosphates, vol. 18 (1994), Elsevier pp. 111-116
10. Yin X., and Stott M.J. α and β-tricalcium phosphate: a density functional study. Physical Review B 68 205 (2003) 1-8
11. 2 bioceramics prepared using a nano size powders. Ceramics International 33 6 (2007) 979-985
12. Orii H., Sotome S., Chen J., Wang J., and Shinomiya K. β tricalcium phosphate (β-TCP) graft combined with bone marrow stromal cell (MSCs) for posterolateral spine fusion. Journal of Medical Dental Science 52 (2005) 51-57
13. 3. Journal of Thermal Analysis and Calorimetry 83 1 (2006) 145-149
14. Gibson I.R., Rehman I., Best S.M., and Bonfield W. Characterization of the transformation from calcium-deficient apatite to β-tricalcium phosphate. Journal of Materials Science: Materials in Medicine 11 12 (2000) 799-804
15. Koc N., Timucin M., and Korkusuz F. Fabrication and characterization of porous tricalcium phosphate ceramics. Ceramics International 30 2 (2004) 205-211
16. Rangavittal N., Landa-Cánovas A.R., Gonzalez-Calbet J.M., and Vallet-Regi M. Structural study and stability of hydroxyapatite and α-tricalcium phosphate: two important bioceramics. Journal Biomedical Materials Research 51 4 (2000) 660-668
17. Lin L.-C., Chang S.-J., Kuo S.M., Chen S.F., and Kuo C.H. Evaluation of chitosan/β-tricalcium phosphate microspheres as a constituent to PMMA cement. Journal of Materials Science: Materials in Medicine 16 (2005) 567-574
18. Santos C., Franke R.-P., Almeida M.M., Costa M.E.V., and Fernandes M.H. Behaviour of Osteoblastic-Like MG-63 Cells Cultured with Hydroxyapatite and Biphasic (Hap/β-TCP) porous granules. Tissue Engineering-Part A 14 5 (2008) 810-1810
19. Kim H.-W., Knowles J.C., and Kim H.-E. Hydroxyapatite/poly(e-caprolactone) composite coating on hydroxyapatite porous bone scaffolds for drug delivery. Biomaterials 25 (2004) 1279-1287
20. Hsu Y.H., Turner I.G., and Miles A.W. Fabrication and mechanical testing of porous calcium phosphate bioceramic granules. Journal of Materials Science: Materials in Medicine 18 10 (2007) 1931-1937
21. Komlev V.S., Barinov S.M., Girardin E., Oscarsson S., Rosengren A., Rustichelli F., and Orlovskii V.P. Porous spherical hydroxyapatite and fluorhydroxyapatite granules: processing and characterization. Science and Technology of Advanced Materials 4 (2003) 503-508
22. Luo P., and Nieh T.G. Synthesis of ultrafine hydroxyapatite particles by a spray dry method. Materials Science and Engineering C3 (1995) 75-78
23. Luo P., and Nieh T.G. Preparing hydroxyapatite powders with controlled morphology. Biomaterials 17 (1996) 1959-1964
24. Ribeiro C.C., Barrias C.C., and Barbosa M.A. Calcium phosphate-alginate microspheres as enzyme delivery matrices. Biomaterials 25 (2004) 4363-4373
25. Paul W., and Sharma C.P. Infection resistant hydroxyapatite/alginate plastic composite. Journal of Materials Science Letters 16 (1997) 2050-2051
26. Zheng Y., Yang W., Wang C., Hu J., Fu S., Dong L., Wu L., and Shen X. Nanoparticles based on the complex of chitosan and polyaspartic acid solution salt: preparation, characterization and the use for 5-fluorouracil delivery. European Journal of Pharmaceutics and Biopharmaceutics 67 (2007) 621-631
27. Lamprecht A., Yamamoto H., Takeuchi H., and Kawashima Y. Microsphere design for the colonic delivery of 5-fluorouracil. Journal of Controlled Release 90 (2003) 313-322
28. Gupte A., and Ciftci K. Formulation and characterization of paclitaxel, 5-FU and Paclitaxel+5-FU microspheres. International Journal of Pharmaceutics 276 (2004) 93-106
29. Arica B., Çalis S., Kas H.S., Sargon M.F., and Hincal A.A. 5-Flourouracil encapsulated alginate beads for the treatment of breast cancer. International Journal of Pharmaceutics 242 (2002) 267-269
30. Bhadra D., Bhadra S., Jain S., and Jain N.K. A PEGylated dendritic nanoparticulate carrier of fluorouracil. International Journal of Pharmaceutics 257 (2003) 111-124
31. Denkbas E.B., Seyyal M., and Piskin E. Implantable 5-fluorouracil loaded chitosan scaffolds prepared by wet spinning. Journal of Membrane Science 172 (2000) 33-38
32. Fournier E., Passirani C., Vonarbourg A., Lemaire L., Colin N., Sagodira S., Menei P., and Benoit J.-P. Therapeutic efficacy study of novel 5-FU-loaded PMM 2. 1. 2-based microspheres on C6 glioma. International Journal of Pharmaceutics 268 (2003) 31-35
33. Qian F., Nasongkla N., and Gao J. Membrane-encased polymer milirods for sustained release of 5-flourouracil. Journal of Biomedical Materials Research 61 (2002) 203-211
34. Landi E., Orlandi L., Spagna G., Tampieri A., and Zaffaroni N. Calcium phosphate ceramics as drug-delivery system for anticancer therapy. Key Engineering Materials 192-195 (2001) 901-904
35. Santos C., Rovath C.F., Franke R.-P., and Almeida M.M. M.E.V. Costa, Spray-dried hydroxyapatite-5-Fluorouracil granules as a chemotherapeutic delivery system. Ceram. Int. 35 (2009) 509-513
36. Chen X., Deng C., Tang S., and Zhang M. Mitochondria-dependent apoptosis induced by nanoscale hydroxyapatite in human gastric cancer SGC-7901 cells. Biological Pharmaceutics Bulletin 30 1 (2007) 128-132
37. Hu J., Liu Z.-S., Tang S., and He Y.-M. Effect of hydroxyapatite nanoparticles on the growth and p53/c-Myc protein expression of implanted hepatic VX2 tumor in rabbits by intravenous injection. World Journal Gastroenterology 13 20 (2007) 2798-2802
38. Martins M.A., Santos C., Almeida M.M., and Costa M.E.V. Hydroxyapatite micro- and nanoparticles: nucleation and growth mechanisms in the presence of citrate species. Journal of Colloid and Interface Science 318 2 (2007) 210-216
39. Gregori G., Kleebe H.-J., Mayr H., and Ziegler G. EELS characterization of β-tricalcium phosphate and hydroxyapatite. Journal of the European Ceramic Society 26 (2006) 1473-1479
40. Santos C., Martins M.A., Almeida M.M., and Costa M.E.V. Adsorption mechanism of 5-Flourouracil on different hydroxyapatite particles. Advanced Materials Forum III 514 (2006) 1103-1110
41. Li X., Xu Y., Chen G., Wei P., and Ping Q. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies. Drug Development and Industrial Pharmacy 34 (2008) 107-115
42. Daculsi G. Biphasic calcium phosphate concept applied to artificial bone, implant coating and injectable bone substitute. Biomaterials 19 (1998) 1473-1478
43. Ng A.M.H., Tan K.K., Phang M.Y., Aziyati O., Tan G.H., Isa M.R., Aminuddin B.S., Naseem M., Fauziah O., and Ruszymah B.H.I. Journal of Biomedical Materials Research Part A 85A 2 (2008) 301-312